References
- Douma C. E., de Waart D. R., Zemel D., Imholz A. L., Koomen G. C., Struijk D. G., et al. Nitrate in stable CAPD patients and during peritonitis. Adv Perit Dial 1995; 11: 36–40
- Yang C. W., Hwang T. L., Wu C. H., Lai P. C., Huang J. Y., Yu C. C., et al. Peritoneal nitric oxide is a marker of peritonitis in patients on continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant 1996; 11: 2466–71
- Stamler J. S., Singel D. J., Loscalzo J. Biochemistry of nitric oxide and its redox activated forms. Science 1992; 258: 1898–902
- Moncada S., Palmer R. M., Higgs E. A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991; 43: 109–42
- Radi R., Cassina A., Hodara R., Quijano C., Castro L. Peroxynitrite reactions and formation in mitochondria. Free Radic Biol Med 2002 Dec 1; 33: 1451–64
- Gawel S., Wardas M., Niedworok E., Wardas P. MDA as a lipid peroxidation marker. Wiad Lek 2004; 57: 453–5
- Del Rio D., Stewart A. J., Pellegrini N. A review of recent studies on malondialdehyde as toxic molecule and biological marker of oxidative stress. Nutr Metab Cardiovasc Dis 2005; 15: 316–28
- Buffone G. J., Lewis S. A., Iosefsohn M., Hicks J. M. Chemical and immunochemical measurement of total iron‐binding capacity compared. Clin Chem 1978; 24: 1788–91
- Smarason A. K., Allman K. G., Young D., Redman C. W. G. Elevated levels of serum nitrate, a stable endproduct of nitric oxide, in women with preeclampsia. Br J Obstet Gynecol 1997; 104: 538–43
- Hunter M. I. S., Nlemadim B. C., Davidson D. L. W. Lipid peroxidation products and antioxidant proteins in plasma and cerebrospinal fluids from multiple sclerosis patients. Neurochem Res 1985; 10: 1645–52
- Vallance P., Collier J. Biology and clinical relevance of nitric oxide. Br Med J 1994; 309: 453–7
- Plum J., Tabatabaei M. M., Lordnejad M. R., Pipinika O., Razeghi P., Huang C., et al. Nitric oxide production in peritoneal macrophages from peritoneal dialysis patients with bacterial peritonitis. Perit Dial Int 1999; 19: 378–83
- Davenport A., Fernando R. L., Varghese Z. Intraperitoneal nitric oxide production in patients treated by continuous ambulatory peritonal dialysis. Blood Purif 2004; 22: 216–23
- Davenport A., Fernando R. L., Robson R., Varghese Z. Nitric oxide production by human peritoneal mesothelial cells. Int J Artif Organs 2004; 27: 15–23
- Marcinkiewicz J., Grabowska A., Chain B. Nitric oxide up‐regulates the release of inflammatory mediators by mouse macrophages. Eur J Immunol 1995; 25: 947–51
- Verger C., Luger A., Moore H. L., Nolph K. D. Acute changes in peritoneal transport properties with infectious peritonitis and mechanical injury. Kidney Int 1983; 23: 823–31
- Krediet R. T., Zuyderhoudt M. J., Boeschoten E. W., Arisz L. Alterations in the peritoneal transport of water and solutes during peritonitis in continuous ambulatory peritoneal dialysis patients. Eur J Clin Invest 1987; 17: 43–52
- Davies S. J., Bryan J., Phillips L., Russell G. I. Longitudinal changes in peritoneal kinetics: the effects of peritoneal dialysis and peritonitis. Nephrol Dial Transplant 1996; 11: 498–506
- Ferrier M. L., Combet S., van Landschoot M., Stoenoiu M. S., Cnops Y., Lameire N., et al. Inhibition of nitric oxide synthase reverses changes in peritoneal permeability in a rat model of acute peritonitis. Kidney Int 2001; 60: 2343–50
- Esterbauer H., Schaur R. J., Zollner H. Chemistry and biochemistry of four hydroxynonenal malondialdehyde and related aldehydes. Free Radicals Biol Med 1991; 62: 81–128
- Karatas F., Karatepe M., Baysar A. Determination of free malondialdehyde in human serum by high performance liquid chromatography. Anal Biochem 2002; 311: 76–9
- Teale D. M., Atkinson A. M. Inhibition of nitric oxide synthesis improves survival in a murine peritonitis model of sepsis that is not cured by antibiotics alone. J Antimicrob Chemother 1992; 30: 839–42